Crossmark

A prospective split-mouth clinical study: comparison of the effect of lornoxicam and etodolac on postoperative sequels following lower third molar surgery

Crossref DOI link: https://doi.org/10.1007/s10006-024-01309-z

Published Online: 2024-11-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karabiyik, Zulfikar

Basiry, Mohammad Nabi
License Information

Text and Data Mining valid from 2024-11-15

Version of Record valid from 2024-11-15
More Information

Article History

Received: 14 August 2024

Accepted: 10 November 2024

First Online: 15 November 2024

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee of Kutahya Health Science University Faculty of Medicine (acceptance number 2022-07/03) and also the Turkish Ministry of Health Medical Drugs and Device Institution with the document number 779718 (date 08/06/2022). The study was registered at clinicaltrials.gov (ID: NCT05679453). Written informed consent was obtained from each patient, all of whom were informed about the study protocol.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below